Impaired production of interferon-alpha in whole-blood cultures from patients with renal cell carcinoma.
To determine the immune status of patients with renal cell carcinoma (RCC) by estimating the production of interferon-alpha (IFN-alpha) in whole-blood cultures from these patients and from healthy subjects. Peripheral blood (2 mL) was collected from 30 untreated patients (23 men and seven women, mean age 59 years, range 35-78) with RCC and 30 healthy subjects (23 men and seven women, mean age 62 years). The patients with RCC comprised 17 with low-stage (stage I, II) and 13 patients with high-stage (stage III, IV) RCC. Sendai virus was added to the samples and incubated at 37 degrees C for 20 h, the supernatants collected and the activity of IFN-alpha determined by a conventional cytopathic-effect inhibition assay performed in microtitre plates with FL cells and challenged with vesicular stomatitis virus. The production of IFN-alpha was suppressed significantly in patients with high-stage RCC compared with that in the control subjects (P < 0.05), but there was no significant difference when compared to patients with low-stage RCC. This study demonstrated that the immune status of patients with high-stage RCC was impaired significantly and exogenous IFN-alpha therapy might be beneficial clinically for this group.